Efficacy of Transfusions with platelets stored in platelet additive solution II versus plasma.

A multicenter randomised study of the efficacy of transfusions with platelets stored in platelet additive solution II versus plasma.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON26192

Enrollment

195

Registered

2005-09-09

Start date

2003-10-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

1. Hemato-oncological patients

Interventions

Platelet transfusion, trigger based.

Eligibility

Inclusion criteria

Inclusion criteria: Patients > 18 years expected to receive platelet transfusions.

Exclusion criteria

Exclusion criteria: HLA- and/or HPA allo-immunization.

Design outcomes

Primary

Measure	Time frame
1- and 24-hour corrected count increment.	—

Secondary

Measure	Time frame
1. Bleeding complications; 2. Transfusion reactions; 3. Transfusion interval.	—

Contacts

Public ContactJ.L.H. Kerkhoffs

HagaHospital, Leyweg 275

J.Kerkhoffs@hagaziekenhuis.nl+31 (0)70 3592004

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)